Poland· PL-100012388
Calcium Resonium
A polystyrene sulfonate product containing calcii polistyreni sulfonas, registered in Poland by Sanofi Winthrop Industrie. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Polystyrene sulfonate is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AE01 (polystyrene sulfonate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Polystyrene sulfonate · ATC V03AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of polystyrene sulfonate costs, country by country.
Normalised to the WHO defined daily dose (45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Polystyrene sulfonate · price per daily dose (45 g)
USD · FX 28 Sept 2026
- CZ Czechia$0.0074
The record
At a glance
URPL (Poland)- Active substance
- Calcii polistyreni sulfonas
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Poland (PL)
- ATC code
- V03AE01
- ATC class
- Polystyrene sulfonate
- Defined daily dose
- 45 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990376216
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V03AE01
Polystyrene sulfonate, as other registers publish it.
- IrelandCalcium Resonium 99.934% Powder for oral or rectal suspensionSanofi-Aventis Ireland Limited T/A SANOFI
- NetherlandsCalciumpolystyreensulfonaat 1 g/g Focus Care, poeder voor suspensie voor oraal/rectaal gebruikFocus Care Pharmaceuticals B.V.
- DenmarkCalciumpolystyrensulfonat CarefarmOrifarm A/S
- CanadaJAMP SODIUM POLYSTYRENE SULFONATEJAMP PHARMA CORPORATION
- CanadaKAYEXALATESANOFI-AVENTIS CANADA INC
- BelgiumKayexalate Calcium 14.99 gSanofi Belgium
- BelgiumKayexalate Sodium 14.99 gSanofi Belgium
- NetherlandsNatriumpolystyreensulfonaat 1 g/g Focus, poeder voor suspensie voor oraal / rectaal gebruikFocus Care Pharmaceuticals B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c6320fd-8005-4287-bfa0-a2d8781e4604 GET /v1/drugs/8c6320fd-8005-4287-bfa0-a2d8781e4604?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek doustny lub do sporządzania zawiesiny doodbytniczej",
"source": "urpl",
"strength": "1,2 g Ca2+/15 g",
"packaging": "05909990376216 ¦ Lz ¦ 43246\n1 op. 300 g",
"substance": "Sulfonianu polistyrenu sól wapniowa 99,934 g/100 g",
"common_name": "Calcii polistyreni sulfonas",
"pl_product_id": "100012388",
"pozwolenie_nr": "03762",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about polystyrene sulfonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.